Asperger syndrome future or investigational therapies: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| (5 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Asperger syndrome}} | {{Asperger syndrome}} | ||
{{CMG}} {{AE}} {{SHA}} | |||
== Overview == | |||
There have been some experimental therapy and suggestions such as [[oxytocin]] and treatment with [[Stem cell|stem cells]] in patients with Asperger Syndrome (AS).<ref name="pmid25655905">{{cite journal| author=Tarazi FI, Sahli ZT, Pleskow J, Mousa SA| title=Asperger's syndrome: diagnosis, comorbidity and therapy. | journal=Expert Rev Neurother | year= 2015 | volume= 15 | issue= 3 | pages= 281-93 | pmid=25655905 | doi=10.1586/14737175.2015.1009898 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25655905 }} </ref> | |||
== Future or Investigational Therapies == | |||
Experimental therapy for Asperger Syndrome (AS) include:<ref name="pmid25655905">{{cite journal| author=Tarazi FI, Sahli ZT, Pleskow J, Mousa SA| title=Asperger's syndrome: diagnosis, comorbidity and therapy. | journal=Expert Rev Neurother | year= 2015 | volume= 15 | issue= 3 | pages= 281-93 | pmid=25655905 | doi=10.1586/14737175.2015.1009898 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=25655905 }} </ref> | |||
=== Oxytocin === | |||
* Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by [[oxytocin]] have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS).<ref name="pmid12496956">{{cite journal| author=Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR | display-authors=etal| title=Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders. | journal=Neuropsychopharmacology | year= 2003 | volume= 28 | issue= 1 | pages= 193-8 | pmid=12496956 | doi=10.1038/sj.npp.1300021 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12496956 }} </ref> | |||
* In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation.<ref name="pmid20160081">{{cite journal| author=Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A| title=Promoting social behavior with oxytocin in high-functioning autism spectrum disorders. | journal=Proc Natl Acad Sci U S A | year= 2010 | volume= 107 | issue= 9 | pages= 4389-94 | pmid=20160081 | doi=10.1073/pnas.0910249107 | pmc=2840168 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20160081 }} </ref> | |||
=== Stem cells === | |||
* Treatment of AS and ASD with [[Stem cell|stem cells]] is in the early stages.<ref name="pmid25655905" /><br /> | |||
==References== | ==References== | ||
Latest revision as of 17:46, 22 June 2020
|
Asperger Syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Asperger syndrome future or investigational therapies On the Web |
|
American Roentgen Ray Society Images of Asperger syndrome future or investigational therapies |
|
FDA on Asperger syndrome future or investigational therapies |
|
CDC on Asperger syndrome future or investigational therapies |
|
Asperger syndrome future or investigational therapies in the news |
|
Blogs on Asperger syndrome future or investigational therapies |
|
Risk calculators and risk factors for Asperger syndrome future or investigational therapies |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Shakiba Hassanzadeh, MD[2]
Overview
There have been some experimental therapy and suggestions such as oxytocin and treatment with stem cells in patients with Asperger Syndrome (AS).[1]
Future or Investigational Therapies
Experimental therapy for Asperger Syndrome (AS) include:[1]
Oxytocin
- Contributions to repetitive behaviors and social deficiencies in Asperger Syndrome (AS) by oxytocin have suggested oxytocin as an experimental therapy in autism spectrum disorder (ASD) and Asperger Syndrome (AS).[2]
- In patients with AS and ASD, the preliminary manipulation of systemic oxytocin levels have suggested a positive correlation in social awareness, social recognition and peer affiliation.[3]
Stem cells
- Treatment of AS and ASD with stem cells is in the early stages.[1]
References
- ↑ 1.0 1.1 1.2 Tarazi FI, Sahli ZT, Pleskow J, Mousa SA (2015). "Asperger's syndrome: diagnosis, comorbidity and therapy". Expert Rev Neurother. 15 (3): 281–93. doi:10.1586/14737175.2015.1009898. PMID 25655905.
- ↑ Hollander E, Novotny S, Hanratty M, Yaffe R, DeCaria CM, Aronowitz BR; et al. (2003). "Oxytocin infusion reduces repetitive behaviors in adults with autistic and Asperger's disorders". Neuropsychopharmacology. 28 (1): 193–8. doi:10.1038/sj.npp.1300021. PMID 12496956.
- ↑ Andari E, Duhamel JR, Zalla T, Herbrecht E, Leboyer M, Sirigu A (2010). "Promoting social behavior with oxytocin in high-functioning autism spectrum disorders". Proc Natl Acad Sci U S A. 107 (9): 4389–94. doi:10.1073/pnas.0910249107. PMC 2840168. PMID 20160081.